Amalgamated Bank’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $21K | Hold |
2,256
| – | – | ﹤0.01% | 2091 |
|
2025
Q1 | $12K | Buy |
2,256
+997
| +79% | +$5.3K | ﹤0.01% | 2280 |
|
2024
Q4 | $9K | Hold |
1,259
| – | – | ﹤0.01% | 2474 |
|
2024
Q3 | $10K | Hold |
1,259
| – | – | ﹤0.01% | 2443 |
|
2024
Q2 | $11K | Hold |
1,259
| – | – | ﹤0.01% | 2384 |
|
2024
Q1 | $26K | Sell |
1,259
-1,827
| -59% | -$37.7K | ﹤0.01% | 2035 |
|
2023
Q4 | $71K | Sell |
3,086
-272
| -8% | -$6.26K | ﹤0.01% | 2113 |
|
2023
Q3 | $27K | Hold |
3,358
| – | – | ﹤0.01% | 2510 |
|
2023
Q2 | $29K | Sell |
3,358
-67
| -2% | -$579 | ﹤0.01% | 2545 |
|
2023
Q1 | $10K | Sell |
3,425
-292
| -8% | -$853 | ﹤0.01% | 2814 |
|
2022
Q4 | $13K | Hold |
3,717
| – | – | ﹤0.01% | 2836 |
|
2022
Q3 | $29K | Buy |
3,717
+29
| +0.8% | +$226 | ﹤0.01% | 2686 |
|
2022
Q2 | $29K | Buy |
3,688
+1,134
| +44% | +$8.92K | ﹤0.01% | 2732 |
|
2022
Q1 | $31K | Buy |
+2,554
| New | +$31K | ﹤0.01% | 2662 |
|
2020
Q2 | – | Sell |
-1,004
| Closed | -$10K | – | 1530 |
|
2020
Q1 | $10K | Buy |
+1,004
| New | +$10K | ﹤0.01% | 1656 |
|